Clinical Trial Update: Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study evaluating the safety and effectiveness of combining temozolomide with M1774 in patients with advanced c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• M1774
• Temodar (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Advanced Microsatellite Stable Colorectal Carcinoma | Phase 1, Phase 2 | Status: RECRUITING